case study: daratumumab in a relapsed patient
Published 6 years ago • 212 plays • Length 3:27Download video MP4
Download video MP3
Similar videos
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
5:07
daratumumab in the management of al amyloidosis
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
0:52
the future of daratumumab in multiple myeloma
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
7:05
hematology oncology rotation | day in the life of a doctor | vlog | bookworm_md
-
17:55
talquetamab | therapies on the horizon
-
1:34
are thrombotic risk and progression in et predictable?
-
1:05
personalized therapy in leukemia: a case study
-
1:03
columba study update: subcutaneous daratumumab in r/r mm
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
-
4:30
andromeda: daratumumab for al amyloidosis
-
3:18
phase i study of cart-ddbcma in r/r multiple myeloma
-
1:05
an overview of the radar trial
-
2:44
myeloma qol through induction and maintenance
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
3:04
monumental-1 update: talquetamab in r/r multiple myeloma